Mylan Pharmaceuticals Inc.
Morgantown, WV
- UEI
- NDN1MYB8DKK5
- CAGE
- 3KJG9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3711 Collins Ferry Rd, Morgantown, WV 26505, USA
- Website
- viatris.com
- Founded
- 2020
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | -$1 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cipla USA Inc. | — | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Sanofi Genzyme | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Idorsia Pharmaceuticals US Inc. | Wayne, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Astellas Pharma US, Inc. | Northbrook, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Mylan Pharmaceuticals Inc. is a corporate entity registered to receive awards from the U.S. federal government since October 2003. As a for-profit manufacturer of pharmaceutical goods, Mylan supplies prescription medications and related products to federal agencies, primarily serving the healthcare needs of U.S. veterans.
Through past prime federal contract awards, Mylan has provided specialty drug products such as clozapine, spironolactone, alprazolam, and thioridazine to the Department of Veterans Affairs National Acquisition Center in support of the VA Pharmaceutical Prime Vendor program. These delivery orders facilitated distribution of critical mental health, cardiovascular, and other medications to VA medical facilities for use in veteran patient care. Mylan also held a prime contract with the Defense Logistics Agency to supply rivastigmine patches used to treat Alzheimer's and Parkinson's disease patients across VA, DoD, Bureau of Prisons, and Indian Health Service locations nationwide.
Mylan currently holds several Indefinite Delivery Contracts to furnish pharmaceuticals to federal customers. A single-award IDC was issued in 2023 by the VA National Acquisition Center for clozapine tablets with a potential value over $8 million. An estimated 19,000+ bottles will be provided annually to supply VA, DoD, BOP and IHS under this 5-year contract. Mylan also holds a Federal Supply Schedule contract with VHA VISN 12 providing a complete range of drugs and hematology products to VA hospitals and clinics. Additionally, in 2022 the Defense Logistics Agency awarded Mylan two separate IDCs valued at $10.9M and $9.5M respectively to supply transdermal patches containing specialty drug products for Alzheimer's disease and women's health.
Quick answers
Is Mylan Pharmaceuticals Inc. registered in SAM.gov?
Yes. Mylan Pharmaceuticals Inc.'s SAM.gov registration is active through February 6, 2027.
Which contract vehicles does Mylan Pharmaceuticals Inc. hold?
Mylan Pharmaceuticals Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Mylan Pharmaceuticals Inc.'s most recent federal award?
Mylan Pharmaceuticals Inc.'s most recent federal contract award is Delivery order for spironolactone for the pharm prepackaging program august 2021 (36E79721N0050), from National Acquisition Center (VA), on August 5, 2021.
On GovTribe
See Mylan Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors